Rafferty Asset Management LLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 18.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,478 shares of the medical device company's stock after selling 4,111 shares during the period. Rafferty Asset Management LLC's holdings in Cooper Companies were worth $1,559,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Shell Asset Management Co. raised its holdings in shares of Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after purchasing an additional 127 shares during the period. UMB Bank n.a. raised its holdings in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after acquiring an additional 129 shares during the period. Horizon Investments LLC raised its holdings in Cooper Companies by 5.0% in the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock valued at $241,000 after acquiring an additional 136 shares during the period. Axxcess Wealth Management LLC raised its holdings in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock valued at $623,000 after acquiring an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC raised its holdings in Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after acquiring an additional 157 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.
Cooper Companies Stock Performance
Shares of COO traded up $0.09 during mid-day trading on Friday, hitting $68.09. 2,759,386 shares of the company's stock were exchanged, compared to its average volume of 2,951,187. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $112.38. The stock's 50-day simple moving average is $71.99 and its 200-day simple moving average is $76.65. The firm has a market cap of $13.54 billion, a price-to-earnings ratio of 33.54, a price-to-earnings-growth ratio of 1.72 and a beta of 0.97. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period last year, the firm earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Analyst Upgrades and Downgrades
COO has been the topic of several research analyst reports. JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday, August 28th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a report on Tuesday, June 17th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a report on Tuesday, July 22nd. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating on the stock in a report on Thursday, August 28th. Finally, Robert W. Baird lowered their price target on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $86.64.
Get Our Latest Stock Analysis on COO
Insider Activity
In other news, COO Gerard H. Warner III purchased 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the transaction, the chief operating officer owned 18,319 shares of the company's stock, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, COO Daniel G. Mcbride purchased 3,000 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the transaction, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 15,975 shares of company stock worth $1,079,566. Insiders own 1.98% of the company's stock.
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Further Reading

Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.